Medicines losing patent protection

MonthYear

December 2027

7 medicines lose their last listed patent or exclusivity in December 2027.

Dec 7Toviazfesoterodine fumarate · Pfizer Inc
Dec 11Valcytevalganciclovir hydrochloride · Cheplapharm Arzneimittel GmbH
Dec 18Incruse Elliptaumeclidinium bromide · Glaxo Group Ltd England dba Glaxosmithkline
Dec 19Oraceadoxycycline · Galderma Laboratories LP
Dec 23Lastacaftalcaftadine · Abbvie Inc
Dec 26Cardenenicardipine hydrochloride · Chiesi USA Inc
Dec 28Tracleerbosentan · Actelion Pharmaceuticals US Inc

Dates are the patent and exclusivity end dates listed in the FDA's Orange Book, in its data up to October 9, 2026. Patents can be extended, challenged in court or settled, so a generic may come earlier, later or not at all. This is not legal or medical advice.

About the data·Privacy·Credits